Fengyuan Tang

Institution: Department of Biomedicine, University of Basel


Mattenstrasse 28, CH-4058, Basel

Email: fengyuan.tang@unibas.ch

Group website: biomedizin.unibas.ch/nc/research/research-group-details/home/researchgroup/tumor-biology/

Phone: 061-207-5055

Research interests:

cancer signaling therapy resistance in cancer

Selected publications:

Tang F*, Gill J, Ficht X, Barthlott T, Schmitz-Rohmer D, Cornils H, Hynx D, Zhou D, Zhang L, Xue G, Grzmil M, Yang Z, Hergovich A, Hollaender GA, Stein JV, Hemmings BA, Matthias P*. The kinases NDR1/2 act downstream of the Hippo homolog MST1 to mediate both egress of thymocytes from the thymus and lymphocyte motility. Science Signaling (2015), 8(394).ra100 Tang F and VanHook AM. Hippo signalling in T cells. Science Signaling (2015), 8(394).pc26 Tang F*, Zhang L, Xue G, Hynx D, Wang Y, Cron PD, Hundsrucker C, Hergovich A, Frank S, Hemmings BA, Schmitz-Rohmer D*. hMOB3 modulates apoptotic MST1 signaling and supports tumor growth in glioblastoma multiforme. Cancer Research (2014), 74(14): 3779-3789 Zhang L, Tang F, Hynx D, Hemmings BA, Schimitz-Rohmer D. Mammalian NDR kinases function as tumor suppressors in the intestinal epithelium. Current Biology (2015), 25(3): 296-305.

Members List